Company attributes
Industry
Location
B2X
CEO
Founder
Pitchbook URL
Number of Employees (Ranges)
11 – 50
Email Address
partners@triumvira.com0
Phone Number
+128977811080
+151279002220
Full Address
9433 Bee Cave Rd Bldg 1 Suite 240, Austin, TX 787330
270 Longwood Rd S Hamilton, ON L8P 0A6, Canada0
Investors
Total Funding Amount (USD)
171,207,326
Latest Funding Round Date
March 21, 2022
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
100,000,000
Triumvira Immunologics offers a proprietary T cell Antigen Coupler (TAC) technology that recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
